CNMD logo

CONMED CorporationNYSE:CNMD Stock Report

Market Cap US$1.6b
Share Price
US$53.12
My Fair Value
US$61
12.9% undervalued intrinsic discount
1Y-21.1%
7D-2.8%
Portfolio Value
​
View

CONMED Corporation

NYSE:CNMD Stock Report

Market Cap: US$1.6b

CONMED (CNMD) Stock Overview

A medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. More details

CNMD fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health3/6
Dividends4/6

Rewards

Trading at 38% below our estimate of its fair value

Earnings are forecast to grow 12.65% per year

Earnings have grown 33.7% per year over the past 5 years

Pays a reliable dividend of 1.51%

Trading at good value compared to peers and industry

Risk Analysis

Debt is not well covered by operating cash flow

Large one-off items impacting financial results


CNMD Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

CNMD logo
CONMED

Rising Costs And Supply Risks Will Impair Future Performance

Key Takeaways Rising cost controls, demographic stagnation, and industry consolidation are expected to constrain revenue growth and increase pricing pressure on CONMED's products. Underinvestment in R&D and geopolitical instability threaten long-term competitiveness by elevating supply costs and risking margin compression.
View narrative
US$55.00
FV
3.4% undervalued intrinsic discount
4.65%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
3 months ago author updated this narrative
CNMD logo
CONMED

Global Aging And Minimally Invasive Trends Will Empower Future Markets

Key Takeaways Focus on minimally invasive surgical solutions, operational efficiencies, and continuous innovation is expected to boost market share and drive sustained revenue and earnings growth. Expansion into emerging markets and improvement in global sales infrastructure are set to diversify revenue streams and support long-term international growth.
View narrative
US$80.00
FV
33.6% undervalued intrinsic discount
6.45%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
25 days ago author updated this narrative
CNMD logo
CONMED

Minimally Invasive Surgeries And Robotics Will Boost Global Healthcare

Key Takeaways Strong positioning in minimally invasive and robotic-assisted surgery, along with regulatory trends and innovation, drives recurring revenue growth and expands long-term market opportunities. Operational improvements and enhanced R&D investment are set to strengthen margins, earnings, and international sales while supporting sustained financial flexibility.
View narrative
US$61.00
FV
12.9% undervalued intrinsic discount
5.69%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
4 days ago author updated this narrative
View Stock Community

CONMED Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for CONMED
Historical stock prices
Current Share PriceUS$53.12
52 Week HighUS$78.19
52 Week LowUS$46.00
Beta1.17
1 Month Change11.50%
3 Month Change-11.86%
1 Year Change-21.14%
3 Year Change-45.94%
5 Year Change-35.08%
Change since IPO2,556.00%

Recent News & Updates

CONMED's (NYSE:CNMD) Solid Profits Have Weak Fundamentals

Aug 08
CONMED's (NYSE:CNMD) Solid Profits Have Weak Fundamentals

Recent updates

CONMED's (NYSE:CNMD) Solid Profits Have Weak Fundamentals

Aug 08
CONMED's (NYSE:CNMD) Solid Profits Have Weak Fundamentals

Are Investors Undervaluing CONMED Corporation (NYSE:CNMD) By 49%?

Jul 03
Are Investors Undervaluing CONMED Corporation (NYSE:CNMD) By 49%?

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

May 24
CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation's (NYSE:CNMD) Shares Bounce 26% But Its Business Still Trails The Market

May 17
CONMED Corporation's (NYSE:CNMD) Shares Bounce 26% But Its Business Still Trails The Market

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 31
Is CONMED (NYSE:CNMD) Using Too Much Debt?

Repeated Disappointments On Growth And Margins Leaves Conmed Even Deeper In The Doghouse

Feb 28

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Feb 28
CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 08
CONMED Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

CONMED Corporation (NYSE:CNMD) Looks Inexpensive But Perhaps Not Attractive Enough

Jan 20
CONMED Corporation (NYSE:CNMD) Looks Inexpensive But Perhaps Not Attractive Enough

Is Now The Time To Look At Buying CONMED Corporation (NYSE:CNMD)?

Jan 01
Is Now The Time To Look At Buying CONMED Corporation (NYSE:CNMD)?

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Dec 13
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Nov 25
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Nov 07
CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 02
Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Oct 01
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

Sep 12
Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price
author-image

Orthopedic And General Surgery Innovations Propel Growth Despite Supply Chain Headwinds

CONMED's focus on resolving supply chain issues will likely bolster product availability, enhancing revenue growth in key segments.

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Aug 15
CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

Jul 17
CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Jun 21

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Jun 01
There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Shareholder Returns

CNMDUS Medical EquipmentUS Market
7D-2.8%0.8%1.0%
1Y-21.1%6.1%17.0%

Return vs Industry: CNMD underperformed the US Medical Equipment industry which returned 6.1% over the past year.

Return vs Market: CNMD underperformed the US Market which returned 17.1% over the past year.

Price Volatility

Is CNMD's price volatile compared to industry and market?
CNMD volatility
CNMD Average Weekly Movement5.4%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.4%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.0%

Stable Share Price: CNMD has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CNMD's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19703,900Pat Beyerwww.conmed.com

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.

CONMED Corporation Fundamentals Summary

How do CONMED's earnings and revenue compare to its market cap?
CNMD fundamental statistics
Market capUS$1.64b
Earnings (TTM)US$110.20m
Revenue (TTM)US$1.33b
14.9x
P/E Ratio
1.2x
P/S Ratio

Is CNMD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CNMD income statement (TTM)
RevenueUS$1.33b
Cost of RevenueUS$582.83m
Gross ProfitUS$743.42m
Other ExpensesUS$633.22m
EarningsUS$110.20m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)3.56
Gross Margin56.05%
Net Profit Margin8.31%
Debt/Equity Ratio87.8%

How did CNMD perform over the long term?

See historical performance and comparison

Dividends

1.5%
Current Dividend Yield
22%
Payout Ratio

Does CNMD pay a reliable dividends?

See CNMD dividend history and benchmarks
When do you need to buy CNMD by to receive an upcoming dividend?
CONMED dividend dates
Ex Dividend DateSep 15 2025
Dividend Pay DateOct 03 2025
Days until Ex dividend28 days
Days until Dividend pay date46 days

Does CNMD pay a reliable dividends?

See CNMD dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/17 16:05
End of Day Share Price 2025/08/15 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CONMED Corporation is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Travis SteedBarclays
Travis SteedBofA Global Research
Kristen StewartCL King & Associates, Inc.